Biologically informed Structure–Gene–Process integration for anticancer drug combination synergy prediction

Accurate prediction of synergistic anticancer drug combinations is important for candidate prioritization in drug discovery, but current methods remain limited in providing biologically structured explanations that connect molecular interactions with cell-context-dependent gene-level signals and downstream biological processes. To address this limitation, we propose SGP-Syn, a biologically informed deep learning approach that establishes a structured Structure–Gene–Process chain. To comprehensively characterize each drug, SGP-Syn integrates complementary ChemBERTa-2 and GINE representations through fine-grained token–node attention. The resulting drug-pair representation is then integrated with cell-line gene expression to derive context-dependent gene-level signals, which are propagated through a Gene Ontology-guided visible neural network to hierarchical biological process representations. Comprehensive evaluations across two drug-combination screening datasets show that SGP-Syn outperforms state-of-the-art methods and generalizes well to unseen drugs and drug pairs, while remaining competitive in unseen-cell-line settings. Beyond predictive performance, multilevel attribution analyses link prediction-relevant molecular substructures to gene-level contributions and hierarchical biological processes, revealing shared and cell-line-specific patterns and providing biologically grounded, testable hypotheses for anticancer drug-combination discovery. SGP-Syn introduces a biologically informed Structure–Gene–Process architecture for anticancer drug synergy prediction. It links prediction-relevant molecular features to gene-level contributions and higher-level biological processes, providing structured cross-level interpretations. This design combines strong predictive performance with biologically structured interpretations for drug-combination discovery and hypothesis generation.

Authors

Institutions

Publication Details

Journal
Journal of Cheminformatics
Published
2026-11-13
DOI
https://doi.org/10.1186/s13321-026-01332-0
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Biologically informed Structure–Gene–Process integration for anticancer drug combination synergy prediction

Yayu Tian, Huanhuan Du, Shouyin Xiao, Shiyu Zhou et al.
Journal of Cheminformatics
Computational Drug Discovery Methods
article

Biologically informed Structure–Gene–Process integration for anticancer drug combination synergy prediction

Yayu Tian, Huanhuan Du, Shouyin Xiao, Shiyu Zhou, Wei Xia, Xingchi Chen, Hongbo Zhu, Xuan He
article en

Abstract

Accurate prediction of synergistic anticancer drug combinations is important for candidate prioritization in drug discovery, but current methods remain limited in providing biologically structured explanations that connect molecular interactions with cell-context-dependent gene-level signals and downstream biological processes. To address this limitation, we propose SGP-Syn, a biologically informed deep learning approach that establishes a structured Structure–Gene–Process chain. To comprehensively characterize each drug, SGP-Syn integrates complementary ChemBERTa-2 and GINE representations through fine-grained token–node attention. The resulting drug-pair representation is then integrated with cell-line gene expression to derive context-dependent gene-level signals, which are propagated through a Gene Ontology-guided visible neural network to hierarchical biological process representations. Comprehensive evaluations across two drug-combination screening datasets show that SGP-Syn outperforms state-of-the-art methods and generalizes well to unseen drugs and drug pairs, while remaining competitive in unseen-cell-line settings. Beyond predictive performance, multilevel attribution analyses link prediction-relevant molecular substructures to gene-level contributions and hierarchical biological processes, revealing shared and cell-line-specific patterns and providing biologically grounded, testable hypotheses for anticancer drug-combination discovery. SGP-Syn introduces a biologically informed Structure–Gene–Process architecture for anticancer drug synergy prediction. It links prediction-relevant molecular features to gene-level contributions and higher-level biological processes, providing structured cross-level interpretations. This design combines strong predictive performance with biologically structured interpretations for drug-combination discovery and hypothesis generation.

Journal of Cheminformatics
Shenyang Ligong University (CN), Peng Cheng Laboratory (CN), Northeastern University (CN)
National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon